ClinicalTrials.Veeva

Menu

Artificial Intelligence-enable Electrocardiogram for Diagnosis and Outcome in Hyperthyroidism

N

National Defense Medical Center, Taiwan

Status

Active, not recruiting

Conditions

Hyperthyroidism

Treatments

Other: AI-enabled ECG-based Screening Tool

Study type

Interventional

Funder types

Other

Identifiers

NCT05675670
NDMC2022001

Details and patient eligibility

About

hyperthyroidism

Enrollment

35,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients in outpatient department.
  • Patients recieved at least 1 ECG examination.
  • Patients without TSH test before ECG examination or patients with subclinical hyperthyroidism without anti-thyroid drug usage.

Exclusion criteria

  • The patients recieved ECG at the period of inactive AI-ECG system.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35,000 participants in 2 patient groups

Intervention
Experimental group
Description:
Patients randomized to intervention will have access to the screening tool
Treatment:
Other: AI-enabled ECG-based Screening Tool
Control
No Intervention group
Description:
Patients randomized to control will continue routine practice.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems